Course ID: 2819
This session will provide a case-centered update on pathogenesis and epidemiology and significance of pulmonary hypertension in parenchymal lung disease. The currently available treatment data and ongoing clinical trials will be discussed.
Oksana Shlobin, M.D., FCCP
Inova Fairfax Medical Campus
Falls Church, Va.
George J. Vuturo, Ph.D., RPh
Chief Compliance Officer
Planning Committee Member
Professional Education Services Group, LLC, Sterling, VA
Janice Agazio, Ph.D., CRNP, RN, FAANP, FAAN
Lead Nurse Planner Planning Committee Member Professional Education Services Group, LLC,
Sterling, VA Assistant Dean for Doctoral Programs and Ordinary Professor School
of Nursing the Catholic University of America, Washington, DC
CME/CE Project Director
Professional Education Services Group, LLC, Sterling VA
This continuing education activity provides continuing education (CE) credits for:
- Pharmacists and Pharmacy Technicians
- Respiratory Therapists
- Social Workers
- Other Related Health Professionals
At the conclusion of this activity participants should be able to:
- Discuss the pathophysiology of PH in chronic fibrotic lung diseases.
- Discuss the impact of PH in chronic lung diseases.
- Review the existing data in chronic fibrotic lung diseases.
8 March 2017
31 December 2017
Estimated Time to Complete This Activity
- This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of Professional Education Services Group and the Pulmonary Hypertension Association. Professional Education Services Group is accredited by the ACCME to provide continuing medical education for physicians. This activity has been approved for a maximum of 0.5 hours of AMA PRA Category 1 Credits™. Physicians should only claim credit to the extent of their participation.
- Professional Education Services Group is an accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides a maximum of 0.5 contact hours of nurse CE credit.
Pharmacists and Pharmacy Technicians
- Professional Education Services Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE UAN 0829-0000-16-191-L04 (Pharmacists) and 0829-0000-16-191-L04 (Pharmacy Technicians). This activity provides 0.5 contact hours (0.10 CEUs) of continuing education credit. There is no cost for this activity. Your record of completion will be reported directly to the CPE Monitor.
- The Continuing Respiratory Education (CRCE) system of the American Association for Respiratory Care (AARC) grants approval for 0.5 hours for this course.
- This program is approved by the National Association of Social Workers for 0.5 Social Work continuing education contact hour.
Instructions for Earning Credit
This activity is a self-study program. In order to claim CE credit, participants must:
- View the content, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be directed to the CE processing center at http://pha.cds.pesgce.com and claim CE credit.
- Complete a post-test and evaluation online. All evaluation questions must be completed in order to receive a CE credit.
- Upon successful completion of the post-test and online evaluation form, you can instantly download and/or print your certificate of credit. Your CE records will be stored at http://pha.cds.pesgce.com for later retrieval at your convenience.
For all CE related inquiries, please contact Support@PESGCE.com or PHA Online University at (301)-565-3004-x771.
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Professional Educational Services Group (PESG) to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty and planners of this educational activity disclose the following:
- Oksana Shlobin, M.D., FCCP, has no financial or nonfinancial arrangements to disclose.
The information presented in this activity reflects the views of the faculty only and not necessarily those of the Pulmonary Hypertension Association (PHA), the sponsors or the educational grant providers. All participants should verify the information and data presented before treating patients or utilizing any therapies noted in these materials. No portion of this activity may be reproduced without the expressed written consent of PHA.
This course requires an internet browser. For optimum display, please use Mozilla Firefox, Safari or Google Chrome.
This activity is made possible through unrestricted educational grants to the PHA Medical Education Fund from Actelion Pharmaceuticals, US; Gilead Sciences, Bayer HealthCare, and United Therapeutics.
©2016 Pulmonary Hypertension Association, 801 Roeder Road, Suite 1000, Silver Spring, MD 21910.